What are the guidelines for grouping, spacing, and numbering characters in a Sequence Listing?
The guidelines for grouping, spacing, and numbering characters in a Sequence Listing are outlined in MPEP 2423.01. Specifically, the MPEP refers to the Code of Federal Regulations for these details:
“37 CFR 1.822(c) through (e) set forth the format for presenting sequence data. These paragraphs set forth the manner in which the characters in sequences are to be grouped, spaced, presented and numbered.”
To ensure compliance with these requirements, applicants should refer to the specific sections of 37 CFR 1.822 mentioned above. These regulations provide detailed instructions on:
- How to group nucleotides and amino acids
- Proper spacing between groups
- Presentation of the sequences
- Numbering conventions for the sequences
It’s crucial to follow these guidelines precisely to avoid potential issues with the patent application process.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2423.01 - Format And Symbols To Be Used In A "Sequence Listing",
Patent Law,
Patent Procedure